In 2007, Dr. Michael Keidar founded The Micro-propulsion and Nanotechnology Laboratory (MpNL) at the George Washington University (GWU) to expand our understanding of plasma and nanoscale phenomena. MpNL researchers focus mainly in three plasma-related applications: (1) propulsion, (2) nanotechnology, and (3) biomedicine.
MpNL research approach combines theoretical and empirical activities in synergy. Our theoretical research is primarily focused on developing analytic models and simulation methods, while our experimental activities aim to validate theoretical models or offer insights not provided by theory. MpNL has an array of sophisticated instrumentation and infrastructure to support fundamental and applied research in plasma and nanoscale physics. MpNL has ongoing collaborations with the GWU Institute for Nanotechnology and Plasma Medicine Program (GWIN/PMP), The GWU School of Medicine and Health Sciences (SMHS), other universities, and government laboratories.
Play this short informational video to learn more about our efforts to sterilize PPE and medical equipment with our newly developed plasma brush.
National Science Foundation (NSF), through their IUCRC program, is sponsoring the Center for High Pressure Plasma Energy, Agriculture, and Biomedical Technologies(C-PEAB), a collaboration between George Washington University, Drexel University, and the University of Michigan. C-PEAB is focused on partnerships with industry to jointly investigate basic plasma science in support of their development efforts in energy, agriculture, and biotechnology sectors. To learn more about the benefits of becoming an industry member, click on the brochure button and visit our web page.
The journal Plasma Medicine is inviting authors to submit articles to a special issue titled Sterilization and Prevention of Infectious Diseases. The deadline for submission is December 1, 2020. For more information click on this link !
The journal nanomaterials is inviting authors to submit articles to a special issue with focus on merging plasma technologies with the multidisciplinary field of nanoscience. Of particular interest is the investigation of plasma nanosynthesis and processing of materials. The deadline to submit is March 12, 2021. For more information click on the attached flyer .
Play this short informational video to learn more about our efforts to treat cancer with cold plasma.
PhD student Position
A PhD student position is opening in the area of cold atmospheric plasma (CAP) for medical application. The main area of research will consist in developing a prototype to activate cancer cells by adaptive CAP. Candidates with a background in electrical engineering or electronics are highly welcome. Interested candidates should send their CV to Prof. Michael Keidar at email@example.com.
Dr. Keidar was recently installed as the A. James Clark Professor of Engineering. For the GW Today article, click here !
In this video, Dr. Keidar discusses the use of cold plasma to treat cancer cells.
See our selected news stories by navigating the slider below. Recent highlights include our efforts to use cold plasma to sanitize personal protective equipment to battle COVID-19 , publication of Dr. Keidar's book Plasma Cancer Therapy , and Dr. Keidar's term as president of the Electric Propulsion Rocket Society .
MpNL is developing medical equipment decontamination system to battle COVID-19.
MpNL hosted the 3rd Industrial Advisory Board meeting of the NSF-funded Industry / University Cooperative Research Center for High Pressure Plasma Energy, Agriculture, and Biomedical Technologies (C-PEAB).
read special issue on plasma medicine published in Plasma journal!
read perspective on plasma treatment of cancer!
MpNL hosted workshop on propulsion for cube sats
MpNL participates in ICOPS 2018
CANYVAL-X satellite with cathode arc thruster launched!
MPNL to participate in NASA's CubeSat Launch Initiative.
GWU thruster licensed by Vector Space.
GWU Researchers’ Plasma Thruster Reaches Space.
Visit the GW Institute for Nanotechnology and Plasma Medicine Program!
MPNL receives grant to expand research on plasma-based cancer therapies.
See more MpNL news!